Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study

Osimertinib showed encouraging efficacy in patients with advanced EGFR T790M-positive NSCLC in previous randomized controlled trials. This real-world study aimed to evaluate the effectiveness and safety of osimertinib in a real-world setting. This observational study (NCT03133234) included 74 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yabing, Qiu, Xibin, Xiao, Guangli, Hu, Hao, Lin, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707565/
https://www.ncbi.nlm.nih.gov/pubmed/31442277
http://dx.doi.org/10.1371/journal.pone.0221575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707565/
https://www.ncbi.nlm.nih.gov/pubmed/31442277
http://dx.doi.org/10.1371/journal.pone.0221575

Ejemplares similares